{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"20.7","upperLimit":"61.1","value":"41.69"},{"groupId":"OG001","lowerLimit":"16.6","upperLimit":"60.3","value":"41.31"},{"groupId":"OG002","lowerLimit":"11.4","upperLimit":"40.5","value":"18.10"},{"groupId":"OG003","lowerLimit":"5.1","upperLimit":"66.8","value":"40.27"},{"groupId":"OG004","lowerLimit":"50.5","upperLimit":"86.2","value":"70.90"},{"groupId":"OG005","lowerLimit":"17.9","upperLimit":"80.5","value":"42.45"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"11"},{"groupId":"OG004","value":"7"},{"groupId":"OG005","value":"6"}],"units":"Participants"}],"title":"T1/2 Hx-DR5-01 Cycle 1 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"29.1","upperLimit":"72.3","value":"37.75"},{"groupId":"OG001","lowerLimit":"21.7","upperLimit":"62.5","value":"39.57"},{"groupId":"OG002","lowerLimit":"16.9","upperLimit":"29.7","value":"24.47"},{"groupId":"OG003","lowerLimit":"36.2","upperLimit":"71.5","value":"49.64"},{"groupId":"OG004","lowerLimit":"29.0","upperLimit":"88.2","value":"33.62"},{"groupId":"OG005","lowerLimit":"54.6","upperLimit":"77.1","value":"65.85"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"7"},{"groupId":"OG004","value":"4"},{"groupId":"OG005","value":"2"}],"units":"Participants"}],"title":"T1/2 Hx-DR5-01 Cycle 2 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"16.2","upperLimit":"84.1","value":"27.64"},{"groupId":"OG001","lowerLimit":"13.1","upperLimit":"66.9","value":"19.93"},{"groupId":"OG002","lowerLimit":"16.2","upperLimit":"24.1","value":"20.16"},{"groupId":"OG003","lowerLimit":"30.8","upperLimit":"60.0","value":"47.86"},{"groupId":"OG004","lowerLimit":"40.1","upperLimit":"64.0","value":"44.51"},{"groupId":"OG005","lowerLimit":"77.00","upperLimit":"77.00","value":"77.00"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"6"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"6"},{"groupId":"OG004","value":"3"},{"groupId":"OG005","value":"1"}],"units":"Participants"}],"title":"T1/2 Hx-DR5-01 Cycle 3 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"12.5","upperLimit":"46.5","value":"35.55"},{"groupId":"OG001","lowerLimit":"15.6","upperLimit":"52.5","value":"34.50"},{"groupId":"OG002","lowerLimit":"14.6","upperLimit":"44.0","value":"19.10"},{"groupId":"OG003","lowerLimit":"26.4","upperLimit":"70.6","value":"36.33"},{"groupId":"OG004","lowerLimit":"35.3","upperLimit":"68.8","value":"42.68"},{"groupId":"OG005","lowerLimit":"16.6","upperLimit":"69.6","value":"37.71"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"8"},{"groupId":"OG001","value":"6"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"11"},{"groupId":"OG004","value":"6"},{"groupId":"OG005","value":"6"}],"units":"Participants"}],"title":"T1/2 Hx-DR5-05 Cycle 1 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"19.3","upperLimit":"71.4","value":"32.46"},{"groupId":"OG001","lowerLimit":"17.3","upperLimit":"80.7","value":"37.71"},{"groupId":"OG002","lowerLimit":"13.9","upperLimit":"62.3","value":"25.43"},{"groupId":"OG003","lowerLimit":"28.4","upperLimit":"43.5","value":"37.69"},{"groupId":"OG004","lowerLimit":"13.1","upperLimit":"29.4","value":"26.68"},{"groupId":"OG005","lowerLimit":"30.8","upperLimit":"73.1","value":"51.97"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"7"},{"groupId":"OG001","value":"4"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"6"},{"groupId":"OG004","value":"3"},{"groupId":"OG005","value":"2"}],"units":"Participants"}],"title":"T1/2 Hx-DR5-05 Cycle 2 Day 1"},{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"12.0","upperLimit":"39.6","value":"25.30"},{"groupId":"OG001","lowerLimit":"15.4","upperLimit":"57.4","value":"18.75"},{"groupId":"OG002","lowerLimit":"24.3","upperLimit":"58.2","value":"41.26"},{"groupId":"OG003","lowerLimit":"14.2","upperLimit":"62.1","value":"33.90"},{"groupId":"OG004","lowerLimit":"13.2","upperLimit":"32.5","value":"22.83"},{"groupId":"OG005","lowerLimit":"70.9","upperLimit":"70.9","value":"70.9"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"5"},{"groupId":"OG001","value":"3"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"6"},{"groupId":"OG004","value":"2"},{"groupId":"OG005","value":"1"}],"units":"Participants"}],"title":"T1/2 Hx-DR5-05 Cycle 3 Day 1"}],"denoms":[{"counts":[{"groupId":"OG000","value":"9"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"4"},{"groupId":"OG003","value":"11"},{"groupId":"OG004","value":"7"},{"groupId":"OG005","value":"6"}],"units":"Participants"}],"description":"The t1/2 of Hx-DR5-01 and Hx-DR5-05 are reported.","dispersionType":"Full Range","groups":[{"description":"Participants received 0.1 mg/kg of GEN1029 every 2 weeks (Q2W) until the end of treatment.","id":"OG000","title":"Biweekly Regimen (GEN1029 0.1 mg/kg)"},{"description":"Participants received 0.2 mg/kg of GEN1029 Q2W until the end of treatment.","id":"OG001","title":"Biweekly Regimen (GEN1029 0.2 mg/kg)"},{"description":"Participants received 0.3 mg/kg of GEN1029 Q2W until the end of treatment.","id":"OG002","title":"Biweekly Regimen (GEN1029 0.3 mg/kg)"},{"description":"Participants received 1.0 mg/kg of GEN1029 Q2W until the end of treatment.","id":"OG003","title":"Biweekly Regimen (GEN1029 1.0 mg/kg)"},{"description":"Participants received 2.0 mg/kg of GEN1029 Q2W until the end of treatment.","id":"OG004","title":"Biweekly Regimen (GEN1029 2.0 mg/kg)"},{"description":"Participants received 3.0 mg/kg of GEN1029 Q2W until the end of treatment.","id":"OG005","title":"Biweekly Regimen (GEN1029 3.0 mg/kg)"}],"paramType":"MEDIAN","populationDescription":"PK analysis set included all participants who were exposed to at least 1 dose of GEN1029 and who had at least 1 post-dose PK measurement. 'Number analyzed' denotes the number of participants evaluated for the specified time point.","reportingStatus":"POSTED","timeFrame":"Predose, end of infusion, 2, 4, 24, 48, 168 and 336 hours after end of infusion on Day 1 of Cycles 1, 2, 3","title":"Half-life Lambda-z (t1/2) of Hx-DR5-01 and Hx-DR5-05","type":"SECONDARY","unitOfMeasure":"h"}